We recently compiled a list of the 11 Best Cosmetic Surgery and Aesthetics Stocks to Invest in Now. In this article, we are ...

The stock's fall snapped a two-day winning streak.

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

But making AbbVie an even more interesting and timely stock to look at, is the fact that in trading on Monday, shares of ABBV ...

We recently published a list of 10 Best Safe Stocks To Buy According to Analysts. In this article, we are going to take a ...

AbbVie has entered into a definitive agreement to acquire Nimble Therapeutics in a deal valued at $200m in cash.

AbbVie Inc. is a strong investment opportunity with promising drugs, steady dividends, and attractive growth potential. Find ...

Breast Reconstruction Market Outlook to 2031The global breast reconstruction market was valued at US$ 1.4 billion in 2021 and is projected to grow at a CAGR of 5.3% from 2022 to 2031, reaching more ...

Friday announced an agreement to acquire Nimble Therapeutics for a cash payment of $200 million at closing, along ...

AbbVie Inc (ABBV) stock saw a decline, ending the day at $173.19 which represents a decrease of $-1.18 or -0.68% from the prior close of $174.37. The stock opened at $174.91 and touched a low of $171.